Posted on 9/9/20
Syros Appoints S. Gail Eckhardt, M.D., to Board
Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced the appointment of S. Gail Eckhardt, M.D.,
Posted on 9/9/20
Kymera Therapeutics Appoints Pamela Esposito and Jeff Albers to its Board of Directors
Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively
Posted on 9/9/20
Forma Therapeutics Appoints Thomas G. Wiggans to Board of Directors
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers
Posted on 9/8/20
Anika Appoint Jack Henneman and Stephen Richard To Board
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention
Posted on 9/8/20
Andrew Hirsch Named CEO of C4 Therapeutics
C4 Therapeutics (C4T), a biopharmaceutical company pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins through degradation
Posted on 9/8/20
Thierry Maupilé Joins as FCC Chairman
Altiostar's Executive Vice President of Strategy & Product Management Thierry Maupilé will speak at the Forum on 5G Open Radio Access Networks, joining industry colleagues
Posted on 9/8/20
Bruker Appoints Bonnie H. Anderson to Board
Bruker Corporation (Nasdaq: BRKR) today announced that it has appointed Bonnie H. Anderson to serve on its board of directors, effective as of September 3, 2020.
Posted on 9/5/20
Election of Lisa McMahon as Chairperson of Western New England Bancorp Board of Directors Highlights Board’s Commitment to Diversity
WESTFIELD, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Western New England Bancorp (NasdaqGS: WNEB) is pleased to announce that on March 24, 2020, Lisa G. McMahon . . .
Posted on 9/4/20
Byrna Technologies Appoints Chris Reed to Board
Byrna Technologies Inc. (OTCQB: BYRN) (CSE: BYRN) today announced the election of Chris Reed to its Board of Directors effective September 1, 2020, as well as . . .
Posted on 9/3/20
Obsidian Therapeutics Appoints Rob Ross, M.D., to Board
Obsidian Therapeutics, Inc., a biotechnology company pioneering controllable cell and gene therapies, today announced the appointment of Robert Ross, M.D., to its Board of Directors.
Posted on 9/3/20
Rallybio Appoints Helen M. Boudreau to Board of Directors
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio, a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders, today announced . . .
Posted on 9/3/20
Indigo Ag Appoints Ron Hovsepian as CEO
Indigo Ag, a company dedicated to harnessing nature to help farmers sustainably feed the planet, today announced that its Board of Directors has selected
Posted on 9/2/20
NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to Board
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative
Posted on 9/2/20
Michael Jordan Join DraftKings as Special Advisor to the Board
Today, DraftKings (Nasdaq: DKNG) welcomed Michael Jordan as a special advisor to the company’s board of directors. The NBA Hall of Fame inductee, six-time NBA Finals . . .
Posted on 9/2/20
Goulston & Storrs Attorney Suma Nair Named to the ACLU of Massachusetts Board of Directors
Goulston & Storrs, an Am Law 200 firm, is pleased to announce that Suma V. Nair, a director in the firm’s Private
Posted on 9/2/20
WWE Elects Steve Pamon to Board of Directors
WWE (NYSE:WWE) today announced that Steve Pamon, President and Chief Operating Officer of Parkwood Entertainment has been elected to its Board of Directors.
Posted on 9/1/20
The Hanover Insurance Group Elects Theodore H. Bunting, Jr. to Board
The Hanover Insurance Group, Inc. (NYSE: THG) announced Theodore H. Bunting, Jr. has been elected to the company's board of directors, effective today.
Posted on 9/1/20
Wellington Management Appoints Jean Hynes CEO
Wellington Management, one of the world’s largest independent investment management firms, today announced that Brendan Swords, Chief Executive Officer, will retire from Wellington on 30 June . . .
Posted on 8/31/20
Agilyx Announces Board Additions to Advance Plastic Circularity
Agilyx AS, a leader in advanced recycling, today announced changes to its Board of Directors.Tim Stedman, Agilyx CEO, and Catherine Keenan of Catherine C. Keenan LLC., . . .
Posted on 8/31/20
Paul Clark Joins Agenus Board of Directors
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers . . .
Posted on 8/31/20
Jennifer Levin Carter MD, MPH, MBA Joins Transparency Life Sciences Advisory Board
Transparency Life Sciences (TLS) today announced the addition of Jennifer Levin Carter M.D., MPH, MBA to the advisory board. Dr. Carter is a healthcare executive and . . .
Posted on 8/31/20
Karyopharm Therapeutics Appoints Christy J. Oliger to its Board of Directors
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of Christy J. Oliger to its Board
Posted on 8/27/20
TruSight Appoints Jonathan Pressman as CEO
TruSight, the financial industry's leading third-party risk utility, today announced the appointment of Jonathan Pressman
Posted on 8/27/20
CEO of Creatio, Katherine Kostereva, Named One of the Top 50 SaaS CEOs for the Third Year in a Row
Creatio (formerly bpm'online), a global software company that provides a leading low-code platform for process management and CRM, today announced that its CEO and Managing Partner, . . .
Posted on 8/26/20
Apnimed Strengthens its Scientific Advisory Board
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apnimed, a clinical-stage pharmaceutical company focused on advancing medicines to treat sleep apnea and related disorders, today announced its Scientific Advisory Board (SAB). The . . .
Boston
